Mdm2 antagonizes the indirect inhibition of p53 and SHP on APOC3, which is probably the underlying mechanism for the involvement of APOC3 in tumorigenesis and cancer progression, and therefore, its implication in NAC response shown in the present work. Here, MDM2 is linked to cancer.